| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA653798 | F | Tested in vitro for the cytotoxic activity against uninfected CEM cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 2. | ALA687756 | F | Compound was evaluated for cytotoxicity by inhibition of mitochondrial DNA synthesis | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 3. | ALA687759 | F | Cytotoxicity in H1 CEM cells | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 4. | ALA697839 | F | Antiviral activity against hepatitis B virus in human hepatoma cell line (2.2.15 cells) | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
| 5. | ALA719100 | F | Tested in vitro for the cytotoxic activity against uninfected MT-4 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 6. | ALA719101 | F | Tested in vitro for the cytotoxic activity against uninfected MT-4 cells at 200 uM | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 7. | ALA757784 | F | Tested in vitro for the antiviral assay in mitogen stimulated human peripheral blood mononuclear (PBM) cells infected with HIV-1 (strain LAV) | Homo sapiens | 13 | assay format | Scientific Literature | ||
| 8. | ALA756466 | F | Tested in vitro for the cytotoxic activity against uninfected human peripheral blood mononuclear (PBM) cells | Homo sapiens | 13 | assay format | Scientific Literature | ||
| 9. | ALA820964 | F | Tested in vitro for the cytotoxic activity against uninfected Vero cells | Chlorocebus sabaeus | 13 | cell-based format | Scientific Literature | ||
| 10. | ALA849596 | F | Selectivity measured as the ratio between IC50 value and EC50 value | 3 | assay format | Scientific Literature | |||
| 11. | ALA832311 | F | Effective concentration against primary human lymphocytes infected with HIV-1LAI | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 12. | ALA833157 | F | Effective concentration against primary human lymphocytes infected with HIV-1LAI | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 13. | ALA877133 | F | Tested for concentration required for increase in lactic acid production in primary mouse bone marrow cells; not active | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA825561 | T | Tested for toxicity against uninfected primary human lymphocytes | Homo sapiens | 1 | assay format | Scientific Literature | ||
| 15. | ALA825215 | A | Tested for concentration required for toxicity against HepG2 cells (5 day assay) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA825216 | A | Tested for concentration required for toxicity against HepG2 cells (5 day assay); no toxicity observed | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA958870 | A | Oral bioavailability in rhesus monkey | Macaca mulatta | 2 | organism-based format | Scientific Literature | ||
| 18. | ALA958875 | A | Cmax in rhesus monkey | Macaca mulatta | 2 | organism-based format | Scientific Literature | ||
| 19. | ALA958876 | A | AUC in rhesus monkey | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA958877 | A | Terminal phase half life in rhesus monkey | Macaca mulatta | 5 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!